Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
Whittemore AS; Balise RR; Pharoah PD; Dicioccio RA; Oakley-Girvan I; Ramus SJ; Daly M; Usinowicz MB; Garlinghouse-Jones K; Ponder BA; Buys S; Senie R; Andrulis I; John E; Hopper JL; Piver MS; British Journal Of Cancer, 2004, vol. 91, issue 11, p 1911, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef